{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T11:40:32Z","timestamp":1792928432784,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Theor Biol Med Model"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1742-4682-11-41","type":"journal-article","created":{"date-parts":[[2014,9,25]],"date-time":"2014-09-25T03:01:07Z","timestamp":1411614067000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Mathematical modeling of multi-drugs therapy: a challenge for determining the optimal combinations of antiviral drugs"],"prefix":"10.1186","volume":"11","author":[{"given":"Yoshiki","family":"Koizumi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Iwami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,25]]},"reference":[{"key":"489_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/373123a0","volume":"373","author":"DD Ho","year":"1995","unstructured":"Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature. 1995, 373: 123-126. 10.1038\/373123a0.","journal-title":"Nature"},{"key":"489_CR2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/373117a0","volume":"373","author":"X Wei","year":"1995","unstructured":"Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P, Lifson JD, Bonhoeffer S, Nowak MA, Hahn BH: Viral dynamics in human immunodeficiency virus type 1 infection. Nature. 1995, 373: 117-122. 10.1038\/373117a0.","journal-title":"Nature"},{"key":"489_CR3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/375193a0","volume":"375","author":"MA Nowak","year":"1995","unstructured":"Nowak MA, Bonhoeffer S, Loveday C, Balfe P, Semple M, Kaye S, Tenant-Flowers M, Tedder R: HIV results in the frame. Results confirmed. Nature. 1995, 375: 193-","journal-title":"Nature"},{"key":"489_CR4","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1126\/science.7824947","volume":"267","author":"JM Coffin","year":"1995","unstructured":"Coffin JM: HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science. 1995, 267: 483-489. 10.1126\/science.7824947.","journal-title":"Science"},{"key":"489_CR5","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1126\/science.271.5255.1582","volume":"271","author":"AS Perelson","year":"1996","unstructured":"Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD: HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science. 1996, 271: 1582-1586. 10.1126\/science.271.5255.1582.","journal-title":"Science"},{"key":"489_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1006\/jtbi.1996.0253","volume":"185","author":"LM Wein","year":"1997","unstructured":"Wein LM, Zenios SA, Nowak MA: Dynamic multidrug therapies for HIV: a control theoretic approach. J Theor Biol. 1997, 185: 15-29. 10.1006\/jtbi.1996.0253.","journal-title":"J Theor Biol"},{"key":"489_CR7","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/387188a0","volume":"387","author":"AS Perelson","year":"1997","unstructured":"Perelson AS, Essunger P, Cao Y, Vesanen M, Hurley A, Saksela K, Markowitz M, Ho DD: Decay characteristics of HIV-1-infected compartments during combination therapy. Nature. 1997, 387: 188-191. 10.1038\/387188a0.","journal-title":"Nature"},{"key":"489_CR8","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1097\/00002030-199812000-00010","volume":"12","author":"DW Notermans","year":"1998","unstructured":"Notermans DW, Goudsmit J, Danner SA, de Wolf F, Perelson AS, Mittler J: Rate of HIV-1 decline following antiretroviral therapy is related to viral load at baseline and drug regimen. AIDS. 1998, 12: 1483-1490. 10.1097\/00002030-199812000-00010.","journal-title":"AIDS"},{"key":"489_CR9","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1006\/jtbi.1997.0622","volume":"192","author":"LM Wein","year":"1998","unstructured":"Wein LM, D\u2019Amato RM, Perelson AS: Mathematical analysis of antiretroviral therapy aimed at HIV-1 eradication or maintenance of low viral loads. J Theor Biol. 1998, 192: 81-98. 10.1006\/jtbi.1997.0622.","journal-title":"J Theor Biol"},{"key":"489_CR10","doi-asserted-by":"publisher","first-page":"12165","DOI":"10.1128\/JVI.77.22.12165-12172.2003","volume":"77","author":"M Di Mascio","year":"2003","unstructured":"Di Mascio M, Markowitz M, Louie M, Hogan C, Hurley A, Chung C, Ho DD, Perelson AS: Viral blip dynamics during highly active antiretroviral therapy. J Virol. 2003, 77: 12165-12172. 10.1128\/JVI.77.22.12165-12172.2003.","journal-title":"J Virol"},{"key":"489_CR11","doi-asserted-by":"publisher","first-page":"4832","DOI":"10.1073\/pnas.0711372105","volume":"105","author":"AR Sedaghat","year":"2008","unstructured":"Sedaghat AR, Dinoso JB, Shen L, Wilke CO, Siliciano RF: Decay dynamics of HIV-1 depend on the inhibited stages of the viral life cycle. Proc Natl Acad Sci U S A. 2008, 105: 4832-4837. 10.1073\/pnas.0711372105.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"489_CR12","doi-asserted-by":"publisher","first-page":"91ra63","DOI":"10.1126\/scitranslmed.3002304","volume":"3","author":"L Shen","year":"2011","unstructured":"Shen L, Rabi SA, Sedaghat AR, Shan L, Lai J, Xing S, Siliciano RF: A critical subset model provides a conceptual basis for the high antiviral activity of major HIV drugs. Sci Transl Med. 2011, 3: 91ra63-","journal-title":"Sci Transl Med"},{"key":"489_CR13","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1038\/nm.2892","volume":"18","author":"DIS Rosenbloom","year":"2012","unstructured":"Rosenbloom DIS, Hill AL, Rabi SA, Siliciano RF, Nowak MA: Antiretroviral dynamics determines HIV evolution and predicts therapy outcome. Nat Med. 2012, 18: 1378-1385. 10.1038\/nm.2892.","journal-title":"Nat Med"},{"key":"489_CR14","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/hep.510280132","volume":"28","author":"S Zeuzem","year":"1998","unstructured":"Zeuzem S, Schmidt JM, Lee JH, von Wagner M, Teuber G, Roth WK: Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover. Hepatology. 1998, 28: 245-252. 10.1002\/hep.510280132.","journal-title":"Hepatology"},{"key":"489_CR15","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1126\/science.282.5386.103","volume":"282","author":"AU Neumann","year":"1998","unstructured":"Neumann AU, Lam NP, Dahari H, Gretch DR, Wiley TE, Layden TJ, Perelson AS: Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science. 1998, 282: 103-107.","journal-title":"Science"},{"key":"489_CR16","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1038\/nature03153","volume":"432","author":"NM Dixit","year":"2004","unstructured":"Dixit NM, Layden-Almer JE, Layden TJ, Perelson AS: Modelling how ribavirin improves interferon response rates in hepatitis C virus infection. Nature. 2004, 432: 922-924. 10.1038\/nature03153.","journal-title":"Nature"},{"key":"489_CR17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/hep.21657","volume":"46","author":"H Dahari","year":"2007","unstructured":"Dahari H, Ribeiro RM, Perelson AS: Triphasic decline of hepatitis C virus RNA during antiviral therapy. Hepatology. 2007, 46: 16-21. 10.1002\/hep.21657.","journal-title":"Hepatology"},{"key":"489_CR18","doi-asserted-by":"publisher","first-page":"6383","DOI":"10.1128\/JVI.02612-08","volume":"83","author":"H Dahari","year":"2009","unstructured":"Dahari H, Sainz B, Perelson AS, Uprichard SL: Modeling subgenomic hepatitis C virus RNA kinetics during treatment with alpha interferon. J Virol. 2009, 83: 6383-6390. 10.1128\/JVI.02612-08.","journal-title":"J Virol"},{"key":"489_CR19","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1053\/jhep.2001.28509","volume":"34","author":"SR Lewin","year":"2001","unstructured":"Lewin SR, Ribeiro RM, Walters T, Lau GK, Bowden S, Locarnini S, Perelson AS: Analysis of hepatitis B viral load decline under potent therapy: complex decay profiles observed. Hepatology. 2001, 34: 1012-1020. 10.1053\/jhep.2001.28509.","journal-title":"Hepatology"},{"key":"489_CR20","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/hep.22586","volume":"49","author":"H Dahari","year":"2009","unstructured":"Dahari H, Shudo E, Ribeiro RM, Perelson AS: Modeling complex decay profiles of hepatitis B virus during antiviral therapy. Hepatology. 2009, 49: 32-38. 10.1002\/hep.22586.","journal-title":"Hepatology"},{"key":"489_CR21","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.jtbi.2008.05.031","volume":"254","author":"CAA Beauchemin","year":"2008","unstructured":"Beauchemin CAA, McSharry JJ, Drusano GL, Nguyen JT, Went GT, Ribeiro RM, Perelson AS: Modeling amantadine treatment of influenza A virus in vitro. J Theor Biol. 2008, 254: 439-451. 10.1016\/j.jtbi.2008.05.031.","journal-title":"J Theor Biol"},{"key":"489_CR22","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jtbi.2010.10.017","volume":"269","author":"HM Dobrovolny","year":"2011","unstructured":"Dobrovolny HM, Gieschke R, Davies BE, Jumbe NL, Beauchemin CAA: Neuraminidase inhibitors for treatment of human and avian strain influenza: A comparative modeling study. J Theor Biol. 2011, 269: 234-244. 10.1016\/j.jtbi.2010.10.017.","journal-title":"J Theor Biol"},{"key":"489_CR23","first-page":"256","volume-title":"Virus Dynamics: Mathematical Principles of Immunology and Virology","author":"M Nowak","year":"2001","unstructured":"Nowak M, May RM: Virus Dynamics: Mathematical Principles of Immunology and Virology. 2001, USA: Oxford University Press, 256-"},{"key":"489_CR24","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/nri700","volume":"2","author":"AS Perelson","year":"2002","unstructured":"Perelson AS: Modelling viral and immune system dynamics. Nat Rev Immunol. 2002, 2: 28-36. 10.1038\/nri700.","journal-title":"Nat Rev Immunol"},{"key":"489_CR25","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.jtbi.2009.06.011","volume":"260","author":"L Rong","year":"2009","unstructured":"Rong L, Perelson AS: Modeling HIV persistence, the latent reservoir, and viral blips. J Theor Biol. 2009, 260: 308-331. 10.1016\/j.jtbi.2009.06.011.","journal-title":"J Theor Biol"},{"key":"489_CR26","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1111\/j.1365-2893.2010.01348.x","volume":"17","author":"J Guedj","year":"2010","unstructured":"Guedj J, Rong L, Dahari H, Perelson AS: A perspective on modelling hepatitis C virus infection. J Viral Hepat. 2010, 17: 825-833. 10.1111\/j.1365-2893.2010.01348.x.","journal-title":"J Viral Hepat"},{"key":"489_CR27","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.3851\/IMP2428","volume":"17","author":"A Chatterjee","year":"2012","unstructured":"Chatterjee A, Guedj J, Perelson AS: Mathematical modelling of HCV infection: what can it teach us in the era of direct-acting antiviral agents?. Antivir Ther. 2012, 17: 1171-1182. 10.3851\/IMP2428.","journal-title":"Antivir Ther"},{"key":"489_CR28","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.antiviral.2009.10.016","volume":"85","author":"T Hawkins","year":"2010","unstructured":"Hawkins T: Understanding and managing the adverse effects of antiretroviral therapy. Antiviral Res. 2010, 85: 201-209. 10.1016\/j.antiviral.2009.10.016.","journal-title":"Antiviral Res"},{"key":"489_CR29","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0031-6997(25)06847-4","volume":"47","author":"WR Greco","year":"1995","unstructured":"Greco WR, Bravo G, Parsons JC: The search for synergy: a critical review from a response surface perspective. Pharmacol Rev. 1995, 47: 331-385.","journal-title":"Pharmacol Rev"},{"key":"489_CR30","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0022-3565(24)29450-7","volume":"298","author":"RJ Tallarida","year":"2001","unstructured":"Tallarida RJ: Drug synergism: its detection and applications. J Pharmacol Exp Ther. 2001, 298: 865-872.","journal-title":"J Pharmacol Exp Ther"},{"key":"489_CR31","first-page":"285","volume":"3","author":"S Loewe","year":"1953","unstructured":"Loewe S: The problem of synergism and antagonism of combined drugs. Arzneimittelforschung. 1953, 3: 285-290.","journal-title":"Arzneimittelforschung"},{"key":"489_CR32","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/j.1744-7348.1939.tb06990.x","volume":"26","author":"CI Bliss","year":"1939","unstructured":"Bliss CI: The toxicity of poisons applied jointly. Ann Appl Biol. 1939, 26: 585-615. 10.1111\/j.1744-7348.1939.tb06990.x.","journal-title":"Ann Appl Biol"},{"key":"489_CR33","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1124\/pr.58.3.10","volume":"58","author":"TC Chou","year":"2006","unstructured":"Chou TC: Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev. 2006, 58: 621-681. 10.1124\/pr.58.3.10.","journal-title":"Pharmacol Rev"},{"key":"489_CR34","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","volume":"70","author":"TC Chou","year":"2010","unstructured":"Chou TC: Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res. 2010, 70: 440-446. 10.1158\/0008-5472.CAN-09-1947.","journal-title":"Cancer Res"},{"key":"489_CR35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","volume":"22","author":"TC Chou","year":"1984","unstructured":"Chou TC, Talalay P: Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul. 1984, 22: 27-55.","journal-title":"Adv Enzyme Regul"},{"key":"489_CR36","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0006-2952(95)02230-9","volume":"51","author":"JJ Martinez-Irujo","year":"1996","unstructured":"Martinez-Irujo JJ, Villahermosa ML, Alberdi E, Santiago E: A checkerboard method to evaluate interactions between drugs. Biochem Pharmacol. 1996, 51: 635-644. 10.1016\/S0006-2952(95)02230-9.","journal-title":"Biochem Pharmacol"},{"key":"489_CR37","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1128\/JVI.01304-06","volume":"81","author":"H Dahari","year":"2007","unstructured":"Dahari H, Ribeiro RM, Rice CM, Perelson AS: Mathematical modeling of subgenomic hepatitis C virus replication in Huh-7 cells. J Virol. 2007, 81: 750-760. 10.1128\/JVI.01304-06.","journal-title":"J Virol"},{"key":"489_CR38","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.jtbi.2010.09.031","volume":"267","author":"AK McLean","year":"2010","unstructured":"McLean AK, Luciani F, Tanaka MM: Trade-offs in resource allocation in the intracellular life-cycle of hepatitis C virus. J Theor Biol. 2010, 267: 565-572. 10.1016\/j.jtbi.2010.09.031.","journal-title":"J Theor Biol"},{"key":"489_CR39","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jtbi.2012.01.023","volume":"300","author":"J Nakabayashi","year":"2012","unstructured":"Nakabayashi J: A compartmentalization model of hepatitis C virus replication: an appropriate distribution of HCV RNA for the effective replication. J Theor Biol. 2012, 300: 110-117.","journal-title":"J Theor Biol"},{"key":"489_CR40","doi-asserted-by":"publisher","first-page":"e1003561","DOI":"10.1371\/journal.ppat.1003561","volume":"9","author":"M Binder","year":"2013","unstructured":"Binder M, Sulaimanov N, Clausznitzer D, Schulze M, H\u00fcber CM, Lenz SM, Schl\u00f6der JP, Trippler M, Bartenschlager R, Lohmann V, Kaderali L: Replication vesicles are load- and choke-points in the hepatitis C virus lifecycle. PLoS Pathog. 2013, 9: e1003561-10.1371\/journal.ppat.1003561.","journal-title":"PLoS Pathog"},{"key":"489_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2004.10.014","volume":"106","author":"DM Jonker","year":"2005","unstructured":"Jonker DM, Visser SA, van der Graaf PH, Voskuyl RA, Danhof M: Towards a mechanism-based analysis of pharmacodynamic drug-drug interactions in vivo. Pharmacol Ther. 2005, 106: 1-10.1016\/j.pharmthera.2004.10.014.","journal-title":"Pharmacol Ther"},{"key":"489_CR42","doi-asserted-by":"publisher","first-page":"5881","DOI":"10.1128\/JVI.00062-14","volume":"88","author":"T Kobayashi","year":"2014","unstructured":"Kobayashi T, Koizumi Y, Takeuchi JS, Misawa N, Kimura Y, Morita S, Aihara K, Koyanagi Y, Iwami S, Sato K: Quantification of Deaminase Activity-Dependent and -Independent Restriction of HIV-1 Replication Mediated by APOBEC3F and APOBEC3G through Experimental-Mathematical Investigation. J Virol. 2014, 88: 5881-5887. 10.1128\/JVI.00062-14.","journal-title":"J Virol"},{"key":"489_CR43","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nrd1609","volume":"4","author":"CT Keith","year":"2005","unstructured":"Keith CT, Borisy AA, Stockwell BR: Multicomponent therapeutics for networked systems. Nat Rev Drug Discov. 2005, 4: 71-78. 10.1038\/nrd1609.","journal-title":"Nat Rev Drug Discov"},{"key":"489_CR44","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/nchembio817","volume":"2","author":"JB Fitzgerald","year":"2006","unstructured":"Fitzgerald JB, Schoeberl B, Nielsen UB, Sorger PK: Systems biology and combination therapy in the quest for clinical efficacy. Nat Chem Biol. 2006, 2: 458-466. 10.1038\/nchembio817.","journal-title":"Nat Chem Biol"},{"key":"489_CR45","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.drudis.2006.11.008","volume":"12","author":"GR Zimmermann","year":"2007","unstructured":"Zimmermann GR, Leh\u00e1r J, Keith CT: Multi-target therapeutics: when the whole is greater than the sum of the parts. Drug Discov Today. 2007, 12: 34-42. 10.1016\/j.drudis.2006.11.008.","journal-title":"Drug Discov Today"},{"key":"489_CR46","doi-asserted-by":"publisher","first-page":"ra68","DOI":"10.1126\/scisignal.2004008","volume":"6","author":"DC Kirouac","year":"2013","unstructured":"Kirouac DC, Du JY, Lahdenranta J, Overland R, Yarar D, Paragas V, Pace E, McDonagh CF, Nielsen UB, Onsum MD: Computational modeling of ERBB2-amplified breast cancer identifies combined ErbB2\/3 blockade as superior to the combination of MEK and AKT inhibitors. Sci Signal. 2013, 6: ra68-","journal-title":"Sci Signal"},{"key":"489_CR47","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nchembio.120","volume":"4","author":"J Leh\u00e1r","year":"2008","unstructured":"Leh\u00e1r J, Stockwell BR, Giaever G, Nislow C: Combination chemical genetics. Nat Chem Biol. 2008, 4: 674-681. 10.1038\/nchembio.120.","journal-title":"Nat Chem Biol"},{"key":"489_CR48","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/msb4100116","volume":"3","author":"J Leh\u00e1r","year":"2007","unstructured":"Leh\u00e1r J, Zimmermann GR, Krueger AS, Molnar RA, Ledell JT, Heilbut AM, Short GF, Giusti LC, Nolan GP, Magid OA, Lee MS, Borisy AA, Stockwell BR, Keith CT: Chemical combination effects predict connectivity in biological systems. Mol Syst Biol. 2007, 3: 80-","journal-title":"Mol Syst Biol"},{"key":"489_CR49","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/msb.2010.32","volume":"6","author":"CM Owens","year":"2010","unstructured":"Owens CM, Mawhinney C, Grenier JM, Altmeyer R, Lee MS, Borisy AA, Leh\u00e1r J, Johansen LM: Chemical combinations elucidate pathway interactions and regulation relevant to Hepatitis C replication. Mol Syst Biol. 2010, 6: 375-","journal-title":"Mol Syst Biol"},{"key":"489_CR50","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1002\/hep.24272","volume":"53","author":"J Guedj","year":"2011","unstructured":"Guedj J, Perelson AS: Second-phase hepatitis C virus RNA decline during telaprevir-based therapy increases with drug effectiveness: implications for treatment duration. Hepatology. 2011, 53: 1801-1808. 10.1002\/hep.24272.","journal-title":"Hepatology"},{"key":"489_CR51","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.jtbi.2010.08.036","volume":"267","author":"J Guedj","year":"2010","unstructured":"Guedj J, Neumann AU: Understanding hepatitis C viral dynamics with direct-acting antiviral agents due to the interplay between intracellular replication and cellular infection dynamics. J Theor Biol. 2010, 267: 330-340. 10.1016\/j.jtbi.2010.08.036.","journal-title":"J Theor Biol"},{"key":"489_CR52","doi-asserted-by":"publisher","first-page":"3991","DOI":"10.1073\/pnas.1203110110","volume":"110","author":"J Guedj","year":"2013","unstructured":"Guedj J, Dahari H, Rong L, Sansone ND, Nettles RE, Cotler SJ, Layden TJ, Uprichard SL, Perelson AS: Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life. Proc Natl Acad Sci U S A. 2013, 110: 3991-3996. 10.1073\/pnas.1203110110.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"489_CR53","doi-asserted-by":"publisher","first-page":"e1002959","DOI":"10.1371\/journal.pcbi.1002959","volume":"9","author":"L Rong","year":"2013","unstructured":"Rong L, Guedj J, Dahari H, Coffield DJ, Levi M, Smith P, Perelson AS: Analysis of hepatitis C virus decline during treatment with the protease inhibitor danoprevir using a multiscale model. PLoS Comput Biol. 2013, 9: e1002959-10.1371\/journal.pcbi.1002959.","journal-title":"PLoS Comput Biol"},{"key":"489_CR54","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.mbs.2013.04.012","volume":"245","author":"L Rong","year":"2013","unstructured":"Rong L, Perelson AS: Mathematical analysis of multiscale models for hepatitis C virus dynamics under therapy with direct-acting antiviral agents. Math Biosci. 2013, 245: 22-30. 10.1016\/j.mbs.2013.04.012.","journal-title":"Math Biosci"},{"key":"489_CR55","doi-asserted-by":"publisher","first-page":"30ra32","DOI":"10.1126\/scitranslmed.3000544","volume":"2","author":"L Rong","year":"2010","unstructured":"Rong L, Dahari H, Ribeiro RM, Perelson AS: Rapid emergence of protease inhibitor resistance in hepatitis C virus. Sci Transl Med. 2010, 2: 30ra32-","journal-title":"Sci Transl Med"}],"container-title":["Theoretical Biology and Medical Modelling"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-4682-11-41.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T20:20:16Z","timestamp":1746390016000},"score":1,"resource":{"primary":{"URL":"https:\/\/tbiomed.biomedcentral.com\/articles\/10.1186\/1742-4682-11-41"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,25]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["489"],"URL":"https:\/\/doi.org\/10.1186\/1742-4682-11-41","relation":{},"ISSN":["1742-4682"],"issn-type":[{"value":"1742-4682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,25]]},"assertion":[{"value":"7 June 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"41"}}